The outcome of primary or secondary liver tumors is poor when resection can not be achieved. Encouraging results of cryosurgery have been reported in unresectable liver tumors, but this treatment needs further evaluation of its efficacy in homogeneous groups of patients. Systemic chemotherapy was used routinely before surgery and after surgery. There was no intraoperative mortality. Cryosurgery is safe and increases the number of patients with unresectable liver malignancies in whom surgery can aim at eradicating the tumor.
Local recurrence is observed more frequently for metastases than for hepatocellular carcinoma.
The benefit in survival is related to the complete treatment of the tumoral disease. PDQ statements exist for a number of topics. Please consult the PDQ Index . The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care.